BioVersys AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	167	143	-	-
Enterprise Value	106	69	-	-
Last Close Price	28.50	24.40	-	-
PS Ratio	52.49	44.94	-	-
PB Ratio	2.79	2.39	-	-
P/TBV Ratio	2.79	2.39	-	-
EV/Sales Ratio	33.35	21.69	-	-
Debt / Equity Ratio	0.36	0.36	1.59	1.86
Net Debt / Equity Ratio	-1.02	-1.02	-1.46	-1.45
Net Debt / EBITDA Ratio	3.06	3.06	0.84	0.71
Net Debt / FCF Ratio	2.74	2.74	1.00	1.06
Asset Turnover	0.05	0.05	0.04	-
Quick Ratio	9.55	9.55	3.51	3.25
Current Ratio	10.10	10.10	3.56	3.59
Return on Equity (ROE)	-61.93%	-61.93%	-194.40%	-
Return on Assets (ROA)	-19.87%	-19.87%	-33.86%	-
Return on Capital Employed (ROCE)	-24.40%	-24.40%	-74.00%	-71.40%
Earnings Yield	-13.10%	-15.30%	-	-
FCF Yield	-13.30%	-15.53%	-	-
Buyback Yield / Dilution	-68.49%	-68.49%	-11.60%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.